Inflammation Flashcards

1
Q

What are the 4 classical descriptions of inflammation?

A

Rubor, tumor, calor and dolor (redness, swelling, heat and pain respectively).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is cellulitis?

List 2 common causes.

A
  • Acute skin infection.
  • Commonly caused by:

1 - Streptococcus pyogenes.

2 - Staphylococcus aureus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the function of inflammation?

A

To destroy, dilute or wall off an injurious agent and induce repair.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List 6 components of barrier immunity.

A

Physical barriers:

1 - Skin.

2 - Lungs.

3 - Gut.

Active barriers:

4 - Cilia.

5 - Secretions.

6 - Antibacterial peptides.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Give an overview of the acute phase response of the innate immune system.

A

1 - Recognition of the danger signal by innate immune cells.

2 - Response mediated by:

  • Cellular activation.
  • Cellular recruitment.
  • Cytokine activation.
  • Complement activation.

3 - Destruction of the pathogen and resolution of inflammation or recruitment of adaptive immune response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How are threats recognised by the innate immune system?

A

Via pattern recognition receptors (especially on mast cells, however pattern recognition receptors are present on every innate immune cell).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List 3 functions of mast cells.

A

1 - To detect injuries via pattern recognition receptors.

2 - To release histamine and other mediators.

3 - To initiate the inflammatory response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

List 3 functions of histamine.

A

1 - To cause vasodilation.

2 - To widen the endothelial junction, increasing permeability.

3 - To cause irritation of nerve endings, causing itching and pain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List 2 mediators of inflammation.

A

1 - Histamine.

2 - Arachidonic acid metabolites (eicosanoids).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

List 3 eicosanoids that mediate inflammation.

Through which pathways are they produced?

A

Through the COX pathway:

1 - Prostaglandins.

2 - Thromboxane.

Through the lipoxygenase pathway:

3 - Leukotrienes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

List 2 effects of COX pathway products.

A

1 - Vasodilation.

2 - Prolongation of oedema.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List 4 effects of leukotrienes.

A

1 - Vasoconstriction.

2 - Chemotaxis.

3 - Increase vascular permeability.

4 - Bronchospasm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is montelukast?

A

A leukotriene receptor antagonist used in asthma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

List 2 drugs that block the COX pathway.

A

1 - Aspirin.

2 - NSAIDs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Give an example of a use of prostaglandins.

A

Prostaglandins are used to treat pulmonary hypertension.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do nonsteroidal anti-inflammatory drugs (NSAIDs) prevent inflammation?

A

By blocking the COX pathway.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the cause of erythema?

A

Vasodilation.

18
Q

What is the cause of oedema?

A

Increased vascular permeability.

19
Q

Which type of proteins are the cause of localised heat during inflammation?

A

Cytokines.

20
Q

List 2 advantages of vasodilation during inflammation.

A

1 - Increases blood flow and pooling, increasing migration of activated cells to the tissues.

2 - Increases local temperature.

21
Q

What is the advantage of increased endothelial permeability during inflammation?

A

The fluid loss into tissue leads to concentration and stasis of red blood cells in local vessels.

22
Q

Why is blood stasis advantageous during inflammation?

A

Because blood stasis contributes towards the migration of immune cells towards the offending agent.

23
Q

List 3 acute phase cytokines.

A

1 - IL-1.

2 - TNF-alpha.

3 - IL-6.

24
Q

List 6 responses of the body to acute phase cytokines.

A

1 - The endothelium vasodilates and increases permeability.

2 - The hypothalamus increases the ‘set’ temperature.

3 - Fat and muscle increase mobilisation of energy stores.

4 - The liver increases production of acute phase proteins such as C-reactive protein (CRP).

5 - The bone marrow increases mobilisation of neutrophils.

6 - Dendritic cells release tumour necrosis factor, which stimulates maturation and migration to lymph nodes (initiates the adaptive immune response).

25
Q

List 3 drugs that are blockers of the acute phase response.

Which diseases are these drugs used to treat?

A

Used to treat inflammatory bowel disease and rheumatoid arthritis:

1 - Anti TNF-alpha.

Used to treat rheumatoid arthritis:

2 - Anti IL-1.

3 - Anti IL-6.

26
Q

What is a risk of overproduction of TNF-alpha and IL-1?

A

Septic shock.

27
Q

List the stages of development of septic shock.

A

1 - Endotoxins (lipopolysaccharides) are released from gram-negative bacteria such as E. coli.

2 - The endotoxins enter the circulation and cause massive activation of macrophages in the liver and spleen.

3 - This results in the overproduction of TNF-alpha and IL-1.

4 - This leads to dilation of blood vessels, leakage of fluid into tissues throughout the body and widespread clotting.

5 - These factors collectively cause multiple organ failure.

28
Q

What are granulomas?

What is their function?

A
  • Large organisations of macrophages.

- They function to wall off infections.

29
Q

List 4 outcomes of acute inflammation.

A

1 - Healing with scar formation.

2 - Abscess formation (encapsulation and pus).

3 - Granuloma formation.

4 - Chronic inflammation (when acute phase can’t be resolved).

30
Q

List 2 factors that might contribute to an unresolved acute phase.

A

1 - Persistent injury or infection.

2 - Autoimmune disease states such as rheumatoid arthritis and systemic lupus erythematosus.

31
Q

List 3 mechanisms of chronic inflammation.

A

1 - Cellular infiltration (granuloma formation).

2 - Tissue destruction by inflammatory cells (such as with COPD).

3 - Attempts at repair with fibrosis and angiogenesis.

32
Q

What is the average lifespan of a neutrophil?

Why is this important?

A
  • Between a few hours and a day.

- This is important for terminating acute inflammation when necessary.

33
Q

List 2 anti-inflammatory cytokines.

A

1 - TGF-beta.

2 - IL-10.

34
Q

How do anti-inflammatory cytokines prevent inflammation?

A

By inhibiting the production of pro-inflammatory cytokines.

35
Q

List 5 acute phase proteins (APPs).

A

1 - C-reactive protein (CRP).

2 - C3.

3 - C4.

4 - Fibrinogen.

5 - Ferritin.

36
Q

List 3 negative control proteins for the acute phase response.

A

1 - Alpha-1 antitrypsin.

2 - Albumin.

3 - Transferrin.

37
Q

List 2 functions of C-reactive protein (CRP).

A

1 - To opsonise bacteria and fungi.

2 - To activate the classical complement cascade by binding to C1q.

38
Q

What is erythrocyte sedimentation rate (ESR)?

A

The rate at which erythrocytes settle out of unclotted blood in one hour.

39
Q

Why does erythrocyte sedimentation rate (ESR) change with inflammation?

A
  • Normally, erythrocytes are very buoyant and settle slowly.
  • Erythrocytes are negatively charged and repel, preventing aggregation.
  • In the presence of acute phase reactants, erythrocytes aggregate due to the loss of their negative charge, resulting in increased sedimentation.
40
Q

What is the effect of IL-1 and IL-6 on bone marrow?

A

Release of neutrophils from bone marrow neutrophil stores.

41
Q

What is a leukaemoid reaction?

What might cause a leukaemoid reaction?

A
  • Leukocytosis in response to stress or infection.

- Can be caused by exaggeration of leukocyte release in response to IL-1 and IL-6 at the bone marrow.